Related Experiment Video
Updated: Jun 17, 2025

Author Spotlight: Advanced Single-Molecule Techniques for Investigating Telomeric Protein-DNA Interactions
Published on: August 30, 2024
Small Molecules Blocking the Assembly of TCAB1 and Telomerase Complexes: Lead Discovery and Biological Activity
Haojie Zuo1, Yiming Ru1, Xiuxiu Gao1
1School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China.
Abstract:
The vast majority of tumor cells maintain the length of the telomeres through a telomerase-dependent maintenance mechanism, allowing for unlimited proliferation. TCAB1 is indispensable for the correct assembly of telomerase complexes and the delivery of telomerase to the telomere. Therefore, this study aimed to explore small molecules capable of interfering with the assembly of TCAB1 and the telomerase complex as novel efficient telomerase inhibitors. Through virtual screening, biological evaluation, and the confirmation of target engagement, the potential ligands of TCAB1 effectively inhibiting telomerase activity were discovered. Among them, compound 9 exhibited telomerase inhibitory activity at a two-digit nanomolar level (IC50 = 0.03 μM), which was dramatically enhanced in comparison with the previously reported telomerase inhibitors. This research, based on the blockage of telomerase assembly through disturbing TCAB1, provides a novel strategy and a potential target for telomerase inhibitor discovery.
Insights
Researchers discovered novel telomerase inhibitors by targeting TCAB1, a protein crucial for telomerase complex assembly. Compound 9 shows potent inhibition, offering a new strategy for cancer therapy development.
Area of Science:
- Molecular Biology
- Biochemistry
- Cancer Research
Background:
- Tumor cells utilize telomerase-dependent mechanisms for unlimited proliferation by maintaining telomere length.
- TCAB1 protein is essential for the proper assembly and telomere delivery of telomerase complexes.
Purpose of the Study:
- To identify small molecules that inhibit telomerase activity by interfering with TCAB1 and telomerase complex assembly.
- To develop novel and efficient telomerase inhibitors for potential therapeutic applications.
Main Methods:
- Virtual screening to identify potential TCAB1 ligands.
- Biological evaluation and target engagement assays to confirm inhibitory activity.
- Determination of IC50 values for lead compounds.
Main Results:
- Discovery of potential ligands that effectively inhibit telomerase activity by targeting TCAB1.
- Compound 9 demonstrated significant telomerase inhibitory activity with an IC50 of 0.03 μM.
- This activity is substantially higher than previously reported telomerase inhibitors.
Conclusions:
- Blocking telomerase assembly via TCAB1 disruption presents a novel strategy for telomerase inhibitor discovery.
- This approach offers a promising new target for developing effective anti-cancer therapeutics.
- Compound 9 represents a potent lead compound for further investigation.
Related Concept Videos
Telomeres and Telomerase
Destabilization of Microtubules
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
Replicative Cell Senescence
Negative Regulator Molecules

